| Features: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Compound of black pepper that boosts bioavailability of curcumin piperine’s bioenhancing function, often more important than piperine’s direct anticancer activity Mechanisms of bioenhancement | Mechanism | Effect | | ----------------------------- | ---------------------------------- | | **↓ CYP3A4, CYP2C9** | Slows metabolic clearance | | **↓ UGT (glucuronidation)** | Increases parent compound exposure | | **↓ P-glycoprotein (ABCB1)** | Improves intracellular retention | | **↑ Intestinal permeability** | Better oral absorption | -Curcumin: ↑ bioavailability ~20–30× -Resveratrol, EGCG, quercetin: ↑ exposure 2–10× Primary pathways: NF-κB, STAT3, PI3K/Akt/mTOR, apoptosis, EMT Direct anticancer potency: modest Bioenhancing value: central and often dominant
|
| Source: |
| Type: |
| Collagen I, primarily composed of two chains encoded by the genes COL1A1 and COL1A2. - Collagen I is the most abundant collagen in the human body and is a major component of the extracellular matrix (ECM), providing structural support to tissues. - It is typically a heterotrimer composed of two α1(I) chains (COL1A1) and one α2(I) chain (COL1A2). - Cancer progression is often accompanied by significant remodeling of the ECM. - Collagen I deposition frequently increases in many solid tumors, contributing to a dense and fibrotic stroma (desmoplasia). - Increased collagen I deposition can lead to higher ECM stiffness, which in turn modifies cell signaling and behavior. Expression Patterns: - Tumors such as breast, pancreatic, colorectal, and lung cancers often exhibit elevated levels of collagen I. - High collagen I expression or deposition in the tumor stroma is frequently correlated with a more aggressive tumor phenotype. |
| 1257- | PI, | Piperlongumine attenuates bile duct ligation-induced liver fibrosis in mice via inhibition of TGF-β1/Smad and EMT pathways |
| - | ex-vivo, | LiverDam, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:133 Target#:1004 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid